Skip to main content
  • MANTA Not Superior to Dual Perclose ProGlides for Large-Bore Arteriotomy Closure in TAVR, Pilot Trial Shows

    An international, two-center, pilot randomized controlled trial of 210 transcatheter aortic valve replacement (TAVR) patients found that the MANTA vascular closure device (VCD) was not superior to dual Perclose ProGlide (PP) closure with regard to access-site-related vascular complications for large-bore arteriotomy closure in TAVR, results released Wednesday show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details